NasdaqGS:FTRELife Sciences
Do Fortrea Holdings' (FTRE) Shrinking Sales Reveal Deeper Strains In Its Growth Strategy?
Fortrea Holdings Inc., a contract research organization spun off from Labcorp in 2023, has recently reported that its sales have declined by an average 2.9% each year over the past four years, alongside returns on capital that remain below zero.
This combination of contracting revenue and ineffective investment decisions suggests earlier profit pools are shrinking and raises fresh questions about the company’s ability to execute its growth plans.
Against this backdrop of multi‑year sales...